Menu Search
Equities

KP Tissue Inc

KPT:TOR

KP Tissue Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CAD)8.49
  • Today's Change-0.03 / -0.35%
  • Shares traded43.63k
  • 1 Year change-17.25%
  • Beta0.3705
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform0
Hold4
Sell0
Strong Sell0

Share price forecast in CAD

The 4 analysts offering 12 month price targets for KP Tissue Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a 6.01% increase from the last price of 8.49.
High17.8%10.00
Med6.0%9.00
Low6.0%9.00

Dividends in CAD

In 2023, KP Tissue Inc reported a dividend of 0.72 CAD, equaling last years dividend. The analyst covering the company expects dividends of 0.72 CAD for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in CAD

On Aug 13, 2024, KP Tissue Inc reported 2nd quarter 2024 earnings of 0.12 per share.
The next earnings announcement is expected on Nov 06, 2024.
Average growth rate-8.70%
KP Tissue Inc reported annual 2023 losses of -0.50 per share on Mar 07, 2024.
Average growth rate+377.79%
More ▼

Revenue history & estimates in CAD

KP Tissue Inc. had 2nd quarter 2024 revenues of 509.80m. This bettered the 492.50m consensus of the 2 analysts covering the company. This was 13.04% above the prior year's 2nd quarter results.
Average growth rate+2.29%
KP Tissue Inc. had revenues for the full year 2023 of 1.87bn. This was 11.39% above the prior year's results.
Average growth rate+7.13%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.